Lifestyle
World's First Cancer Vaccine Cuts Risk Of Metastasis By 38%: How Personalised Shots Train The Immune System To Work?
Cancer treatment could be moving towards a more personalised approach, where the therapy is designed not just for the type of cancer a person has, but for the genetic characteristics of their individual tumour.
By Tanya Dutt26K reads

Cancer treatment could be moving towards a more personalised approach, where the therapy is designed not just for the type of cancer a person has, but for the genetic characteristics of their individual tumour.
A personalised cancer vaccine developed by Moderna and Merck has delivered strong results in a large Phase 3 trial. When given alongside the immunotherapy drug Keytruda after surgery, the vaccine reduced the risk of melanoma returning or death by 42% and lowered the risk of the cancer spreading to other parts of the body by 38%.



